A Sionna Therapeutics (SION) Insider Sold 33,000 Shares for $1.5 Million
This clinical-stage biotech focused on cystic fibrosis therapies reported a notable insider sale amid a year of sharp ownership reductions.
Read more
Dan Walters: Did state’s issues scare off governor candidates?
California faces a half-dozen existential issues that threaten the state’s future economic and social wellbeing, and they have persistently defied attempts to resolve them over the last 25 years. Read Full Article →
Community Rumors Suggest Ozak AI Might Enter Multiple Exchanges Simultaneously, Enabling 15×–60× Jumps
Ozak AI draws attention alongside Pyth Network and Dex3 as cryptocurrency investors watch exchange listing speculation. Read Full Article →
Qianhai to strengthen role as key partner to Hong Kong
A new action plan released by the Qianhai authorities in Shenzhen aims to strengthen its position as a “key partner” to Hong Kong rather than a competitor, further bolstering the city’s status as a global hub for finance, trade and talent.The 2026 action plan, released recently by authorities,
China Opens Door to Nvidia H200 Chips But Questions Outnumber Answers
China has reportedly indicated willingness to approve NVIDIA (NASDAQ:NVDA) H200 chips for import. The timing, conditions, and competitive dynamics present a complex situation for the company’s China market strategy. The Approval That Isn’t Really an Approval Jensen Huang is currently in Shanghai. China is “poised to approve”
